Article
[Genetics of weight gain associated with antipsychotic medications].
Der Nervenarzt - 1 May 2009
Müller D J, Peter C, Puls I, Brandl E J, Lang U E, Gallinat J, Heinz A
Abstract excerpt
Weight gain is a serious adverse event during neuroleptic or antipsychotic treatment of schizophrenic disorders. The risk of weight gain varies among the class of neuroleptics, however no reliable predictors exist that adequately estimate individual risk. It is hoped that molecular genetic tests will help determine individual risk in the future. This article summarizes studies performed till now and concludes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
